Clinical trials

A deeper analysis of the landmark Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial – that ultimately recommended selective laser...

The Centre for Eye Research Australia (CERA) has established Cerulea Clinical Trials, a new specialist ophthalmic clinical trial facility in...

The Lions Eye Institute (LEI) clinical trials team has rebranded as ‘Lions Vision Trials’ to establish a unique identity that...

Melbourne-linked biopharmaceutical company Azura Ophthalmics has announced positive results from a Phase 2 clinical trial of its investigational dry eye...

Clinical trials innovator and digital health expert Ms Michelle Gallaher has been appointed the inaugural CEO of Cerulea, a new...

A $2.9 million funding injection from the Federal Government will support the rollout of a new saliva-based genetic test for...

Apellis Pharmaceuticals has responded to “positive” 24-month data for its pioneering geographic atrophy (GA) therapy published in The Lancet, demonstrating...

Astellas Pharma has announced positive 24-month topline results from the GATHER2 Phase 3 clinical study of IZERVAY, developed by its...

Novartis will discontinue development of GT005 gene therapy, a subretinal injection for geographic atrophy (GA), in a blow to the...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...